Sampath‐Kumar Anandan

Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia

Le-Ning Zhang, Jon Vincelette, Ying Cheng et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 114 citations · Full text

1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia

Sampath‐Kumar Anandan, Heather K. Webb, Dawn Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 72 citations · Full text

Medicinal Chemistry, Oxysterol, Biochemistry +7

Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension

Le-Ning Zhang, Jon Vincelette, Dawn Chen et al. · European Journal of Pharmacology · 2010 · 71 citations

Soluble Epoxide Hydrolase, Metabolic Syndrome, Biochemistry +13

N- and C-terminal modifications of negamycin

B. China Raju, Kathleen H. Mortell, Sampath‐Kumar Anandan et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 53 citations

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +9

Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors

Sampath‐Kumar Anandan, John S. Ward, Richard D. Brokx et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 35 citations · Full text

Histone Modifications, Molecular Pharmacology, Medicinal Chemistry +7